ROCKEFELLER UNIVERSITY

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Molecular Characteristics of Brodalumab in Hidradenitis Suppurativa

Early Phase 1
Completed
Conditions
Interventions
First Posted Date
2021-07-28
Last Posted Date
2022-07-27
Lead Sponsor
Rockefeller University
Target Recruit Count
4
Registration Number
NCT04979520
Locations
πŸ‡ΊπŸ‡Έ

The Rockefeller University, New York, New York, United States

Time-Restricted Feeding

First Posted Date
2021-05-13
Last Posted Date
2022-08-24
Lead Sponsor
Rockefeller University
Target Recruit Count
10
Registration Number
NCT04884659
Locations
πŸ‡ΊπŸ‡Έ

The Rockefeller University Hospital, New York, New York, United States

RU Anti-SARS-CoV-2 (COVID-19) mAbs in Healthy Volunteers

Phase 1
Completed
Conditions
Interventions
First Posted Date
2021-01-07
Last Posted Date
2022-08-04
Lead Sponsor
Rockefeller University
Target Recruit Count
23
Registration Number
NCT04700163
Locations
πŸ‡ΊπŸ‡Έ

The Rockefeller University, New York, New York, United States

An Alternative Dose Interval Study in Participants With Hidradenitis Suppurativa Receiving Brodalumab

Early Phase 1
Withdrawn
Conditions
Interventions
First Posted Date
2020-01-31
Last Posted Date
2020-09-04
Lead Sponsor
Rockefeller University
Registration Number
NCT04249713
Locations
πŸ‡ΊπŸ‡Έ

Rockefeller University Hospital, New York, New York, United States

3BNC117-LS and 10-1074-LS in Viremic HIV-infected Individuals

First Posted Date
2020-01-31
Last Posted Date
2023-06-26
Lead Sponsor
Rockefeller University
Target Recruit Count
6
Registration Number
NCT04250636
Locations
πŸ‡ΊπŸ‡Έ

Weill Cornell Medical Center Clinical Trials Unit-CLOSED SITE, New York, New York, United States

πŸ‡ΊπŸ‡Έ

Perelman School of Medicine University of Pennsylvania, Philadelphia, Pennsylvania, United States

πŸ‡ΊπŸ‡Έ

The Rockefeller University, New York, New York, United States

When the Kidney Reacts to Nutritional Changes

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2019-10-29
Last Posted Date
2021-08-05
Lead Sponsor
Rockefeller University
Target Recruit Count
9
Registration Number
NCT04142138
Locations
πŸ‡ΊπŸ‡Έ

The Rockefeller University, New York, New York, United States

Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab.

Early Phase 1
Withdrawn
Conditions
Interventions
First Posted Date
2019-09-10
Last Posted Date
2020-06-05
Lead Sponsor
Rockefeller University
Registration Number
NCT04084665
Locations
πŸ‡ΊπŸ‡Έ

Rockefeller Unviersity, New York, New York, United States

A Study Investigating the Safety and Tolerability of an Immune Treatment in Cancer Patients With Lesions to the Skin

Phase 1
Completed
Conditions
Interventions
First Posted Date
2019-08-16
Last Posted Date
2024-04-17
Lead Sponsor
Rockefeller University
Target Recruit Count
16
Registration Number
NCT04059588
Locations
πŸ‡ΊπŸ‡Έ

Rockefeller University, New York, New York, United States

DASH Diet Intervention at Senior Centers

First Posted Date
2019-06-21
Last Posted Date
2020-12-09
Lead Sponsor
Rockefeller University
Target Recruit Count
94
Registration Number
NCT03993808
Locations
πŸ‡ΊπŸ‡Έ

Carter Burden Network Leonard Covello Center, New York, New York, United States

Biomarkers In Hidradenitis Suppurativa Participants Receiving Brodalumab

Early Phase 1
Completed
Conditions
Interventions
First Posted Date
2019-05-23
Last Posted Date
2020-06-04
Lead Sponsor
Rockefeller University
Target Recruit Count
10
Registration Number
NCT03960268
Locations
πŸ‡ΊπŸ‡Έ

Rockefeller Unviersity, New York, New York, United States

Β© Copyright 2024. All Rights Reserved by MedPath